Born in the UK in 1949 and schooled in London, Peter studied Botany and Biochemistry at the universities of Reading and London before doing his PhD in Genetics at Tübingen University in Germany. His research career started in London where he investigated bioenergetic problems in mitochondria and chloroplasts. In Tübingen he worked on bacteriophage DNA replication before writing his PhD about making and characterising monoclonal antibodies as probes of eukaryotic chromosomes. He was a lecturer at the University of Düsseldorf in Germany and received a large WHO grant for molecular biological research on the human parasite Schistosoma mansoni. Moving to commerce in 1990, he was CEO of successful Biotech start-ups in Germany, Austria, and Hungary. He is still a consultant for the Hungarian company SCICONS, the world’s only supplier of monoclonal antibodies against double stranded RNA that are very actively being used by scientists investigating SARS-CoV-2.
Subjects: Biochemistry, Biology, Biomedical Science
Division: Natural Sciences
Position: Module leader